Curie.Bio
Sarah DeVos has extensive experience in the biopharmaceutical field, currently serving as Drug Maker in Residence at Curie.Bio. Previous roles include Director and Principal Scientist at Denali Therapeutics, along with positions as Associate Director and Senior Scientist, Lab Leader. Early career experience includes a postdoctoral fellowship at Massachusetts General Hospital and a PhD candidacy in Neuroscience at Washington University in St. Louis, where Sarah earned a degree from 2009 to 2014. Sarah also holds a Bachelor of Science in Neuroscience from Central Michigan University, completed from 2005 to 2009.
This person is not in any teams
Curie.Bio
2 followers
Curie.Bio is a founder-focused seed-stage venture firm combined with an industry-grade therapeutics accelerator focused on one thing: helping entrepreneurial founders launch viable therapeutics companies. Curie.Bio does this by giving founders access to a team of the world’s best drug hunters and drug makers, seed capital, and best-of-breed services - everything a founder needs to get from concept to a compelling quality dataset that enables an awesome Series A financing. In a nutshell, we want founders in control of their own company and focused on their area of expertise and creativity, while we help make the rest happen smoothly.